BR112014009406A2 - uso de derivados de avermectina para aumentar a biodisponibilidade e eficácia de lactonas macrocíclicas - Google Patents
uso de derivados de avermectina para aumentar a biodisponibilidade e eficácia de lactonas macrocíclicasInfo
- Publication number
- BR112014009406A2 BR112014009406A2 BR112014009406A BR112014009406A BR112014009406A2 BR 112014009406 A2 BR112014009406 A2 BR 112014009406A2 BR 112014009406 A BR112014009406 A BR 112014009406A BR 112014009406 A BR112014009406 A BR 112014009406A BR 112014009406 A2 BR112014009406 A2 BR 112014009406A2
- Authority
- BR
- Brazil
- Prior art keywords
- group
- efficacy
- macrocyclic lactones
- avermectin
- increase bioavailability
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
- C07D493/20—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Saccharide Compounds (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11306348 | 2011-10-18 | ||
PCT/EP2012/070704 WO2013057222A2 (en) | 2011-10-18 | 2012-10-18 | Use of avermectin derivative for increasing bioavailability and efficacy of macrocylic lactones |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112014009406A2 true BR112014009406A2 (pt) | 2017-04-18 |
Family
ID=47143857
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014009406A BR112014009406A2 (pt) | 2011-10-18 | 2012-10-18 | uso de derivados de avermectina para aumentar a biodisponibilidade e eficácia de lactonas macrocíclicas |
Country Status (7)
Country | Link |
---|---|
US (3) | US11130776B2 (pt) |
EP (2) | EP3701954A3 (pt) |
AU (4) | AU2012324876A1 (pt) |
BR (1) | BR112014009406A2 (pt) |
CA (1) | CA2852607C (pt) |
ES (1) | ES2777928T3 (pt) |
WO (1) | WO2013057222A2 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103588784B (zh) * | 2013-11-14 | 2015-12-30 | 大连九信生物化工科技有限公司 | 一种制备高纯度尼莫克汀的方法 |
CN108498537A (zh) * | 2018-06-25 | 2018-09-07 | 塔里木大学 | 一种灭杀动物体外寄生虫的制剂及其制备方法 |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5595756A (en) * | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
US5778436A (en) | 1995-03-06 | 1998-07-07 | Duke University | Predictive caching system and method based on memory access which previously followed a cache miss |
WO1999063441A1 (en) | 1998-06-05 | 1999-12-09 | Mylex Corporation | Snapshot backup strategy |
GB9825402D0 (en) | 1998-11-19 | 1999-01-13 | Pfizer Ltd | Antiparasitic formulations |
US7734591B1 (en) | 1999-08-16 | 2010-06-08 | Netapp, Inc. | Coherent device to device data replication |
US6434681B1 (en) | 1999-12-02 | 2002-08-13 | Emc Corporation | Snapshot copy facility for a data storage system permitting continued host read/write access |
AUPQ634300A0 (en) * | 2000-03-20 | 2000-04-15 | Eli Lilly And Company | Synergistic formulations |
AU2005202712B2 (en) * | 2000-03-20 | 2007-08-23 | Elanco Us Inc. | Synergistic formulations |
JP3868708B2 (ja) | 2000-04-19 | 2007-01-17 | 株式会社日立製作所 | スナップショット管理方法及び計算機システム |
CA2418975C (en) * | 2000-08-09 | 2012-01-17 | Satoshi Omura | Avermectin derivatives |
ATE320812T1 (de) | 2000-10-10 | 2006-04-15 | Wyeth Corp | Anthelmintika |
US6941490B2 (en) | 2000-12-21 | 2005-09-06 | Emc Corporation | Dual channel restoration of data between primary and backup servers |
US6711662B2 (en) | 2001-03-29 | 2004-03-23 | Intel Corporation | Multiprocessor cache coherence management |
US20030064941A1 (en) * | 2001-05-21 | 2003-04-03 | Pfizer Inc. | Avermectin and praziquantel combination therapy |
US7296125B2 (en) | 2001-11-29 | 2007-11-13 | Emc Corporation | Preserving a snapshot of selected data of a mass storage system |
US7085785B2 (en) | 2002-02-15 | 2006-08-01 | International Business Machines Corporation | Writable file system snapshot with ditto address feature |
US7743031B1 (en) | 2002-09-06 | 2010-06-22 | 3Par, Inc. | Time and space efficient technique for creating virtual volume copies |
US7165145B2 (en) | 2003-07-02 | 2007-01-16 | Falconstor Software, Inc. | System and method to protect data stored in a storage system |
US6959313B2 (en) | 2003-07-08 | 2005-10-25 | Pillar Data Systems, Inc. | Snapshots of file systems in data storage systems |
JP4466001B2 (ja) | 2003-08-06 | 2010-05-26 | 株式会社日立製作所 | スナップショット高速化方法 |
US7035881B2 (en) | 2003-09-23 | 2006-04-25 | Emc Corporation | Organization of read-write snapshot copies in a data storage system |
US7225210B2 (en) | 2003-11-20 | 2007-05-29 | Overland Storage, Inc. | Block level data snapshot system and method |
US7671034B2 (en) * | 2003-12-19 | 2010-03-02 | Merial Limited | Stabilized formulation of ivermectin feed premix with an extended shelf life |
US7440966B2 (en) | 2004-02-12 | 2008-10-21 | International Business Machines Corporation | Method and apparatus for file system snapshot persistence |
EP1632498A1 (en) * | 2004-09-03 | 2006-03-08 | Syngenta Participations AG | Derivatives of avermectin, avermectin monosaccharide and avermectin aglycone |
US7363435B1 (en) | 2005-04-27 | 2008-04-22 | Sun Microsystems, Inc. | System and method for coherence prediction |
US20070055710A1 (en) | 2005-09-06 | 2007-03-08 | Reldata, Inc. | BLOCK SNAPSHOTS OVER iSCSI |
US7426618B2 (en) | 2005-09-06 | 2008-09-16 | Dot Hill Systems Corp. | Snapshot restore method and apparatus |
US7751348B2 (en) | 2005-11-04 | 2010-07-06 | Cisco Technology, Inc. | Method and system for providing a push-to-talk communication session |
US7774316B2 (en) | 2005-11-30 | 2010-08-10 | Oracle International Corp. | Filesystem snapshot enhancement to improve system performance |
EP1816563B1 (en) | 2006-01-26 | 2016-04-27 | Infortrend Technology, Inc. | Method of managing data snapshot images in a storage system |
US7676514B2 (en) | 2006-05-08 | 2010-03-09 | Emc Corporation | Distributed maintenance of snapshot copies by a primary processor managing metadata and a secondary processor providing read-write access to a production dataset |
US7757057B2 (en) | 2006-11-27 | 2010-07-13 | Lsi Corporation | Optimized rollback of copy-on-write snapshot volumes |
US7676510B1 (en) | 2006-12-22 | 2010-03-09 | Network Appliance, Inc. | Space reservation monitoring in a fractionally reserved data storage system |
US7870356B1 (en) | 2007-02-22 | 2011-01-11 | Emc Corporation | Creation of snapshot copies using a sparse file for keeping a record of changed blocks |
US7792802B1 (en) | 2007-03-02 | 2010-09-07 | 3Par, Inc. | Archiving logs with snapshots for data recovery |
ES2595499T3 (es) | 2007-05-03 | 2016-12-30 | Merial, Inc. | Composiciones que comprenden compuestos de alcoxiéter macrólidos C-13 y compuestos de fenilpirazol |
WO2008150413A1 (en) | 2007-05-29 | 2008-12-11 | Brandeis University | Device and method for enabling long-lived snapshots |
US8364639B1 (en) | 2007-10-11 | 2013-01-29 | Parallels IP Holdings GmbH | Method and system for creation, analysis and navigation of virtual snapshots |
BRPI0705822A2 (pt) * | 2007-10-25 | 2009-06-23 | Schering Plough Saude Animal Ltda | formulação injetável com ação prolongada e uso de um agente semi-sintético derivado do grupo das avermectinas, em combinação com um polìmero biodegradável |
US20090187719A1 (en) | 2008-01-17 | 2009-07-23 | Inventec Corporation | Data backup method for logical volume manager |
CN102548413A (zh) | 2009-08-07 | 2012-07-04 | 加特微胶囊股份公司 | 包含大环内酯阿维菌素、弥拜菌素、齐墩螨素、米尔倍霉素、埃玛菌素、伊维菌素和一般的mectins的微囊 |
US20120225123A1 (en) * | 2009-11-09 | 2012-09-06 | University Health Network | Use of Synergistic Combinations of an Avermectin and an Antineoplastic Compounds for the Treatment of Hematological Malignancies |
UA108641C2 (uk) | 2010-04-02 | 2015-05-25 | Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування | |
US8281096B1 (en) | 2010-06-02 | 2012-10-02 | Symantec Corporation | Systems and methods for creating snapshots |
WO2012030383A1 (en) | 2010-08-31 | 2012-03-08 | Falconstor, Inc. | Data deduplication |
US8880820B2 (en) | 2010-09-08 | 2014-11-04 | Novell, Inc. | Techniques for using sparse files during snapshots |
US8402008B2 (en) | 2010-09-10 | 2013-03-19 | International Business Machines Corporation | Handling file operations with low persistent storage space |
US8874524B1 (en) | 2012-06-22 | 2014-10-28 | Emc Corporation | Handling copy on first write data for snapshot purposes |
US9304901B2 (en) | 2013-03-14 | 2016-04-05 | Datadirect Networks Inc. | System and method for handling I/O write requests |
US9218139B2 (en) | 2013-08-16 | 2015-12-22 | International Business Machines Corporation | Minimally disruptive virtual machine snapshots |
US9298633B1 (en) | 2013-09-18 | 2016-03-29 | Emc Corporation | Adaptive prefecth for predicted write requests |
CN107406497A (zh) * | 2014-12-19 | 2017-11-28 | 埃博灵克斯股份有限公司 | 半胱氨酸连接的纳米抗体二聚体 |
RU2571551C1 (ru) * | 2015-04-16 | 2015-12-20 | Закрытое акционерное общество "ПЕПТЕК" | Специфическая сочетанная терапия злокачественных опухолей цитостатиком и его модификатором |
-
2012
- 2012-10-18 CA CA2852607A patent/CA2852607C/en active Active
- 2012-10-18 US US14/352,669 patent/US11130776B2/en active Active
- 2012-10-18 AU AU2012324876A patent/AU2012324876A1/en not_active Abandoned
- 2012-10-18 WO PCT/EP2012/070704 patent/WO2013057222A2/en active Application Filing
- 2012-10-18 EP EP19215890.5A patent/EP3701954A3/en not_active Withdrawn
- 2012-10-18 BR BR112014009406A patent/BR112014009406A2/pt not_active Application Discontinuation
- 2012-10-18 ES ES12783158T patent/ES2777928T3/es active Active
- 2012-10-18 EP EP12783158.4A patent/EP2768513B8/en active Active
-
2017
- 2017-08-23 AU AU2017219002A patent/AU2017219002A1/en not_active Abandoned
-
2018
- 2018-05-24 US US15/988,073 patent/US11021508B2/en active Active
-
2019
- 2019-06-13 AU AU2019204133A patent/AU2019204133A1/en not_active Abandoned
-
2020
- 2020-10-30 AU AU2020260537A patent/AU2020260537B9/en not_active Expired - Fee Related
-
2021
- 2021-05-04 US US17/307,722 patent/US20210261594A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US11021508B2 (en) | 2021-06-01 |
EP2768513B8 (en) | 2020-05-20 |
CA2852607A1 (en) | 2013-04-25 |
EP2768513B1 (en) | 2019-12-25 |
AU2012324876A1 (en) | 2014-05-01 |
US11130776B2 (en) | 2021-09-28 |
CA2852607C (en) | 2021-05-04 |
EP3701954A2 (en) | 2020-09-02 |
AU2019204133A1 (en) | 2019-07-04 |
US20140256619A1 (en) | 2014-09-11 |
AU2020260537B2 (en) | 2021-10-21 |
EP2768513A2 (en) | 2014-08-27 |
WO2013057222A2 (en) | 2013-04-25 |
US20180265536A1 (en) | 2018-09-20 |
AU2017219002A1 (en) | 2017-09-07 |
NZ623929A (en) | 2016-09-30 |
AU2020260537B9 (en) | 2021-11-04 |
AU2020260537A1 (en) | 2020-11-26 |
ES2777928T3 (es) | 2020-08-06 |
EP3701954A3 (en) | 2021-04-21 |
WO2013057222A3 (en) | 2013-08-22 |
US20210261594A1 (en) | 2021-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112013021337A2 (pt) | agente de controle de endoparasita e método para controlar endoparasitas | |
BR112012026950A2 (pt) | composto, e, uso de um composto | |
BR112016005270A2 (pt) | compostos de aza-piridona, composições farmacêuticas e seus usos | |
BR112012019762A2 (pt) | composto, composição, e, método para tratar uma doença. | |
CR20160220A (es) | PIRROLO [1,2-f][1,2,4] TRIAZINAS ÚTILES PARA TRATAR INFECCIONES POR EL VIRUS SINCITIAL RESPIRATORIO | |
WO2016081203A3 (en) | Phospholipid ether analogs as cancer-targeting drug vehicles | |
EA201500173A1 (ru) | Фунгицидные композиции | |
BR112013010310A2 (pt) | inibidores de acetil-coa carboxilase de lactama n1/n2 | |
BR112014017749A8 (pt) | Composto alquinilbenzeno 3,5-dissubstituído e sal do mesmo | |
CR20140197A (es) | Compuestos con actividad nematicida | |
BR112014018990A8 (pt) | Derivados de ácido benzotiazol-6-il acético e seu uso para tratamento de uma infecção | |
BR112012030408A2 (pt) | método de melhoramento de culturas | |
BR112014002202A2 (pt) | macrociclos como inibidores de fator xia | |
BR112016010080A8 (pt) | compostos de pirazolopirimidina, composição farmacêutica e seu uso | |
CO6382125A2 (es) | Inhibidores de proteína quinasa | |
CO6382126A2 (es) | Compuestos heteroaromaticos fusionados y espirociclicos para el tratamiento de infecciones bacterianas | |
EA201201648A1 (ru) | Стимуляторы sgc | |
BR112012014858A2 (pt) | agente antiplaqueta | |
NI201300111A (es) | Derivados de pirazoloespirocetona para uso como inhibidores de acetil-coa carboxilasa | |
NI201200017A (es) | Formulación farmacéutica | |
BR112015018509A2 (pt) | compostos de imidazo piridina | |
BR112015010779A2 (pt) | moduladores de di-hidropirazol gpr40 | |
BR112015010791A2 (pt) | moduladores de gpr40 de di-hidropirazol | |
BR112016024571A2 (pt) | composto de 1,2,4-triazina dissubstituído | |
EA201492023A1 (ru) | Регуляторы пути комплемента и их применение |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B25D | Requested change of name of applicant approved |
Owner name: THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/ MCGILL UNIVERSITY (CA) ; INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT (FR) |
|
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B25L | Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled |
Owner name: THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/ MCGILL UNIVERSITY (CA) ; INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) Free format text: ANULADA A PUBLICACAO CODIGO 25.4 NA RPI NO 2648 DE 05/10/2021 POR TER SIDO INDEVIDA. |
|
B25D | Requested change of name of applicant approved |
Owner name: THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/ MCGILL UNIVERSITY (CA) ; INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT (FR) |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |